Kalaris to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference

Rhea-AI Summary

Kalaris Therapeutics (Nasdaq: KLRS) announced that management will present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference.

Presentation details: Matthew Feinsod, Chief Medical Officer, will present on Wednesday, December 3, 2025 from 11:30–11:55 AM ET at Florida Atlantic University in Boca Raton, FL. Management will be available for one-on-one meetings by arrangement with conference representatives.

Berkeley Heights, New Jersey--(Newsfile Corp. - November 24, 2025) - Kalaris Therapeutics, Inc. (Nasdaq: KLRS) ("Kalaris"), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced that management will present at the upcoming Noble Capital Markets 21st Annual Emerging Growth Equity Conference.

Details:

• Type: Company presentation
• Speakers: Matthew Feinsod, Chief Medical Officer
• Date: Wednesday, December 3, 2025
• Time: 11:30 - 11:55 am ET
• Location: Florida Atlantic University, Boca Raton, FL

Kalaris management will be available for one-on-one meetings during the conference. Interested parties should contact their conference representative to arrange a meeting.

About Kalaris

Kalaris Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases with major unmet medical needs. Founded by renowned scientist Dr. Napoleone Ferrara, whose pioneering research led to the development of anti-VEGF therapy, the company is committed to advancing novel therapeutic approaches for patients with sight-threatening retinal conditions such as neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).

For more information, visit www.kalaristx.com.

Kalaris Therapeutics Investor Contact:

Corey Davis, Ph.D.
LifeSci Advisors, LLC
+1 212 915 2577
cdavis@lifesciadvisors.com
ir@kalaristx.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275547

FAQ

When will Kalaris (KLRS) present at the Noble Capital Markets conference?

Kalaris will present on Wednesday, December 3, 2025 from 11:30–11:55 AM ET.

Who will speak for Kalaris (KLRS) at the December 3, 2025 presentation?

Matthew Feinsod, Chief Medical Officer, is listed as the company speaker.

Where is the Noble Capital Markets 21st Annual Emerging Growth Equity Conference presentation by KLRS taking place?

The presentation is at Florida Atlantic University, Boca Raton, FL.

How can investors arrange a one-on-one meeting with Kalaris (KLRS) at the conference?

Interested parties should contact their conference representative to arrange one-on-one meetings with Kalaris management.

Will Kalaris (KLRS) provide a webcast or recording of the December 3, 2025 presentation?

No webcast or recording was specified; attendees should contact investor relations or their conference representative for access details.

What topics will Kalaris (KLRS) likely cover at the Noble Capital Markets presentation on December 3, 2025?

The company indicated a management presentation; specific agenda topics were not listed in the announcement.